The world's first clinical study for treating heart failure with so-called iPS cells could start in Japan in the coming months as the country's health ministry approved a plan by Osaka University on Wednesday.

Under the plan, the university will place induced pluripotent stem cells into heart muscle cell sheets and transplant them into the hearts of the patients.

The plan was given the green light on the condition that the university thoroughly explains to the patients about the risks of using other people's cells in the treatment.